MarketPeel
Insider Trading Intelligence
Pricing
…
NM

Nicole Murphy

BIIB
HEAD OF PHARM OPS AND TECH · BIOGEN INC. · CIK 0001910644
FILING MIX · LIFETIME37%/63%
BUYS
29
SELLS
49
TOTAL VALUE
$2.07M
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
10,560
AVG SELL PX
$212.44
TRADE KIND
SHOWING 78 / 78
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Nicole Murphy, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-1.75%+0.47%-2.22%-2.22%—
14d1+0.00%-3.83%+1.18%-5.00%-5.00%—
30d1+0.00%-7.14%-2.79%-4.35%-4.35%—
60d1+0.00%-9.79%+0.71%-10.49%-10.49%—
90d1+100.00%+4.62%+8.96%-4.34%-4.34%—
180d1(1 pending)——————
1y1(1 pending)——————
2y1(1 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BIIB · 10,560 shares · as of Feb 13, 2026
05,25410,50815,76221,0162023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 29 buys / 49 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
10,560——10,560Feb 13, 2026Feb 17, 2026 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
3$195.04$58519,611.041Feb 12, 2026Feb 17, 2026 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
1,940——17,247.041Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
1,940——1,940Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
4,683——21,016.041Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
1,408$201.18$283.3K19,608.041Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
4,683——9,367Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
914$201.18$183.9K16,333.041Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
2,102——0Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
2,102——16,324.041Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
1,017$201.18$204.6K15,307.041Feb 6, 2026Feb 10, 2026 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
2,272——0Feb 10, 2025Feb 12, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
2,272——14,725.374Feb 10, 2025Feb 12, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
670$142.54$95.5K14,055.374Feb 10, 2025Feb 12, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
1,940——13,056.374Feb 7, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
1,940——3,880Feb 7, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
603$141.35$85.2K12,453.374Feb 7, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
2,102——2,102Feb 7, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
2,102——11,736.374Feb 7, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
620$141.35$87.6K11,116.374Feb 7, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
14,050——14,050Feb 6, 2025Feb 10, 2025 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
240——0Apr 1, 2024Apr 3, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
240——9,751.374Apr 1, 2024Apr 3, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
117$214.83$25.1K9,634.374Apr 1, 2024Apr 3, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
404——504Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
404——9,613.99Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
414$219.08$90.7K9,209.99Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
196$219.08$42.9K9,417.99Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
856——9,623.99Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
504——0Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
856——0Feb 16, 2024Feb 21, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
2,272——2,272Feb 9, 2024Feb 13, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
2,272——9,528.99Feb 9, 2024Feb 13, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
761$240.98$183.4K8,767.99Feb 9, 2024Feb 13, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
2,101——7,894.99Feb 8, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
2,101——4,204Feb 8, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
638$240.30$153.3K7,256.99Feb 8, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
5,820——5,820Feb 7, 2024Feb 9, 2024 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
856——856Jan 29, 2024Jan 31, 2024 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
116$278.03$32.3K5,702.29Mar 31, 2023Apr 4, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
239——240Mar 31, 2023Apr 4, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
239——5,818.29Mar 31, 2023Apr 4, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
480——1,334Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
480——5,579.29Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
233$278.38$64.9K5,099.29Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
426——908Feb 17, 2023Feb 22, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
340——6,034.29Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
165$286.30$47.2K5,332.29Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
685$286.30$196.1K5,694.29Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
416——0Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
340——416Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
2,271——6,379.29Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
2,271——4,544Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
537$286.30$153.7K5,497.29Feb 10, 2023Feb 14, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
6,305——6,305Feb 8, 2023Feb 10, 2023 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
1,340——4,108.29Jan 25, 2023Jan 27, 2023 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
39$298.90$11.7K2,768.29Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
131——2,807.29Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
131——0Dec 2, 2022Dec 6, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
825——2,919.29Aug 1, 2022Aug 3, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
243$209.26$50.9K2,676.29Aug 1, 2022Aug 3, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
299——255Aug 1, 2022Aug 3, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
255——0Aug 1, 2022Aug 3, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
76$209.26$15.9K2,094.29Aug 1, 2022Aug 3, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
825——0Aug 1, 2022Aug 3, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
255——2,170.29Aug 1, 2022Aug 3, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
239——479Apr 1, 2022Apr 5, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
84$210.65$17.7K1,812.89Apr 1, 2022Apr 5, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
239——1,896.89Apr 1, 2022Apr 5, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
110$209.79$23.1K1,657.89Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
535——1,814Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
371——1,767.89Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
371——2,349Feb 18, 2022Feb 23, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASE
Head of Pharm Ops and Tech
263——1,488.89Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
92$214.59$19.7K1,396.89Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
489——756Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
SALE
Head of Pharm Ops and Tech
263——1,245Feb 12, 2022Feb 15, 2022 ↗View →
BIIB
BIOGEN INC.
PURCHASEGRANT
Stock grant
6,815——6,815Feb 10, 2022Feb 14, 2022 ↗View →
Other insiders · BIIB
Loading peer insiders…
About this filer
CIK 0001910644
ROLE
Head of Pharm Ops and Tech
PRIMARY
BIIB
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001910644DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback